Rezolute, Inc. (RZLT)
4.685
+0.06
(+1.41%)
USD |
NASDAQ |
Aug 31, 16:00
4.685
0.00 (0.00%)
After-Hours: 18:41
Rezolute Cash and Short Term Investments (Quarterly) : 120.27M for March 31, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 120.27M |
| December 31, 2025 | 132.94M |
| September 30, 2025 | 152.19M |
| June 30, 2025 | 167.86M |
| March 31, 2025 | 86.89M |
| December 31, 2024 | 96.54M |
| September 30, 2024 | 108.27M |
| June 30, 2024 | 126.87M |
| March 31, 2024 | 80.02M |
| December 31, 2023 | 92.60M |
| September 30, 2023 | 98.73M |
| June 30, 2023 | 101.90M |
| March 31, 2023 | 103.06M |
| December 31, 2022 | 146.75M |
| September 30, 2022 | 154.32M |
| June 30, 2022 | 150.41M |
| March 31, 2022 | 63.42M |
| December 31, 2021 | 77.40M |
| September 30, 2021 | 37.29M |
| June 30, 2021 | 41.05M |
| March 31, 2021 | 31.99M |
| December 31, 2020 | 37.60M |
| September 30, 2020 | 6.404M |
| June 30, 2020 | 9.955M |
| March 31, 2020 | 14.03M |
| Date | Value |
|---|---|
| December 31, 2019 | 19.71M |
| September 30, 2019 | 25.22M |
| June 30, 2019 | 11.57M |
| March 31, 2019 | 15.34M |
| December 31, 2018 | 0.2582M |
| September 30, 2018 | 0.4009M |
| June 30, 2018 | 1.646M |
| March 31, 2018 | 0.0781M |
| December 31, 2017 | 0.8681M |
| September 30, 2017 | 4.016M |
| June 30, 2017 | 4.486M |
| March 31, 2017 | 4.437M |
| December 31, 2016 | 3.573M |
| September 30, 2016 | 3.366M |
| June 30, 2016 | 4.062M |
| March 31, 2016 | 1.746M |
| December 31, 2015 | 1.708M |
| September 30, 2015 | 2.803M |
| June 30, 2015 | 5.729M |
| March 31, 2015 | 8.675M |
| December 31, 2014 | 8.590M |
| September 30, 2014 | 4.298M |
| June 30, 2014 | 5.934M |
| March 31, 2014 | 5.642M |
| December 31, 2013 | 1.145M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 138.44M |
| AbbVie, Inc. | 6.569B |
| Marker Therapeutics, Inc. | 11.92M |
| Avalo Therapeutics, Inc. | 400.32M |
| Krystal Biotech, Inc. | 845.63M |